Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.

求助中 10 由 ! 发布于 2024/11/5 0:04:07

DOI:10.1358/dot.2022.58.10.3408812
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1358/dot.2022.58.10.3408812

其它数据库

Abstract：Antibody-drug conjugates (ADC), a combination of cytotoxic drugs and antibodies, have emerged as a rising star in cancer therapy. Disitamab vedotin (RC48), a novel ADC targeting human epider

应助信息

等您来应助

上传文件

4小时前

小丹

202411051019470909952.pdf 已驳回

14小时前

Book学术机器人

2024/11/5 0:04:07 未找到该文献，机器人已退出，请等待人工下载

2024/11/5 0:04:07 Book学术AI机器人收到请求，开始寻找文献

2024/11/5 0:04:07 已向机器人发送请求

14小时前

! 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库[A real world study on the relationship between drug resistance of targeted therapy and prognosis of HER-2-positive advanced breast cancer].